A total of 9% of placebo recipients contracted COVID-19 from a household member, compared with 2.9% of ensitrelvir recipients ...

Based upon a successful engagement with the US Food and Drug Administration (FDA) at the End-of-Phase 2 meeting in January ...

The United Laboratories International Holdings Limited (OTCMKTS:ULIHF – Get Free Report) was the target of a significant growth in short interest during the month of February. As of February 28th, ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...

Burn victims are being treated at hospitals throughout Europe, and officials are urging proper precautions be taken to ...

In a new study, results suggest that in a preclinical model, two FDA-approved flu antivirals did not successfully treat severe H5N1 infections. Additionally, the researchers found that the route of ...

In two recent interviews on Fox News, HHS Secretary Robert F. Kennedy Jr. downplayed concerns about H5N1 avian influenza in ...

New RNA-based active agents reliably protect plants against the Cucumber mosaic virus (CMV), the most common virus in agriculture and horticulture. They were developed by researchers at the Martin ...

Scientists at IIT Roorkee have achieved a major breakthrough by identifying a potential drug for the treatment of chikungunya ...

Anthony Albanese will lower the cost of medicines to no more than $25 in an election-eve play for millions of votes, as the ...

Researchers at Martin Luther University have developed groundbreaking RNA-based agents that offer high levels of protection ...

Thousands of Minnesotans remain exhausted and disabled after their COVID-19 illnesses, but why they got “long COVID” while ...